Swiss National Bank
CUE icon

Swiss National Bank’s Cue Biopharma CUE Stock Holding History

Swiss National Bank’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,253
Closed -$330K – 2755
2022
Q1 		$330K Buy
2,253
+170
+8% +$36K ﹤0.01% 2654
2021
Q4 		$707K Hold
2,083
– – ﹤0.01% 2580
2021
Q3 		$911K Buy
2,083
+70
+3% +$24.4K ﹤0.01% 2466
2021
Q2 		$704K Buy
2,013
+166
+9% +$64.3K ﹤0.01% 2580
2021
Q1 		$676K Buy
1,847
+67
+4% +$27.6K ﹤0.01% 2426
2020
Q4 		$668K Buy
1,780
+60
+3% +$24K ﹤0.01% 2420
2020
Q3 		$777K Buy
1,720
+140
+9% +$80.7K ﹤0.01% 2226
2020
Q2 		$1.16M Buy
+1,580
New +$1.14M ﹤0.01% 2024

Other funds holding CUE

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Swiss National Bank's CUE Position: Q2 2022 in Review

Swiss National Bank sold out of Cue Biopharma (CUE) in Q2 2022, closing a stake of 2,253 shares — an estimated $330K sold.

Swiss National Bank first reported a position in CUE in Q2 2020 and held it in 8 quarters. The position peaked at $1.16M in Q2 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2022.

  • Swiss National Bank reported no remaining Cue Biopharma position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 2,253 Cue Biopharma shares in Q2 2022, an estimated $330K.
  • Swiss National Bank first reported a position in Cue Biopharma in Q2 2020 and held it in 8 quarters.
  • Swiss National Bank's Cue Biopharma position peaked at $1.16M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.